Cargando…
Treatment options for unresectable hepatocellular carcinoma with hepatitis virus infection following sorafenib failure
BACKGROUND: Currently, there are a few treatment options for unresectable hepatocellular carcinoma (HCC) after progression following sorafenib (SOR) therapy, but with limited benefit. The purpose of this study was to investigate the efficacy and safety of tyrosine kinase inhibitors (TKIs) combined w...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10198937/ https://www.ncbi.nlm.nih.gov/pubmed/36441192 http://dx.doi.org/10.1007/s00262-022-03324-z |